Quantcast

Latest Lupus Stories

2014-10-09 00:20:40

Empire State Building Glows Purple to Celebrate Lupus Foundation of America's National Gala and to Call Attention to Need for Increased Awareness and Investment in Lupus Research NEW YORK, Oct. 8, 2014 /PRNewswire-USNewswire/ -- On Wednesday, October 8, patients, caregivers, researchers, celebrities and supporters gathered at Gotham Hall in New York City for the Lupus Foundation of America's Evening of Hope National Gala. The event raised critical funds needed to support the...

2014-10-06 16:27:08

NORWALK, Conn., Oct. 6, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network, a leading online community for rheumatologists, features major coverage of new advances against lupus, which is the focus of Lupus Awareness Month in October. Lupus, which affects at least 300,000 Americans, is an autoimmune disease in which the body's immune system attacks its own tissues and organs, including the skin, the kidneys, and the brain. Last week the US National Institutes of Health...

2014-10-02 12:31:37

WASHINGTON, Oct. 2, 2014 /PRNewswire-USNewswire/ -- Sandra C. Raymond, President & CEO of the Lupus Foundation of America issued the following statement in response to Eli Lilly and Company's announcement of the results of two Phase III clinical trials of tabalumab, a biologic agent studied for the treatment of lupus. Unfortunately, the trials did not show favorable results and the company is terminating these studies. The halting of the studies was not based on safety concerns....

2014-10-02 08:29:46

INDIANAPOLIS, Oct. 2, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today it will discontinue development of tabalumab­ -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns. ­­­­ In the ILLUMINATE 1 study, tabalumab did not achieve the primary endpoint, at either dose studied, of statistically significant...

2014-09-30 12:29:58

WASHINGTON, Sept. 30, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, announced four grants that will allow lupus investigators to continue critical lupus research. An additional grant has been awarded to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis. http://photos.prnewswire.com/prnvar/20121113/DC11393LOGO The Lupus Foundation of...

2014-09-26 08:25:39

Comedian Jo Koy will serve as Walk Ambassador for San Francisco's Walk to End Lupus Now on October 26th WASHINGTON, Sept. 26, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will host its annual Walk To End Lupus Now(TM )event in San Francisco on Sunday, October 26, 2014 at Golden Gate Park. Walk Ambassador, comedian Jo Koy, will join thousands of San Francisco residents to raise money for lupus research and education programs, increase awareness of the disease, and...

2014-09-15 12:27:50

Hundreds Step Up For New Lupus Treatments NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Over 200 patients, families, physicians and scientists came together under one roof Saturday to learn, interact and participate in the drive for better lupus treatments at New York City's first Lupus Trials Fair launched by the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation. Attendees interacted directly with researchers at eight of NYC's leading institutions -- sharing experiences,...

2014-09-09 12:28:50

Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing WASHINGTON, Sept. 9, 2014 /PRNewswire-USNewswire/ -- Today, the Lupus Foundation of America, the only national force devoted to solving the mystery of lupus, and the Rheumatology Research Foundation, the largest private funding source of rheumatology research and training programs, convened on Capitol Hill to update our nation's leaders about the new Accelerating Medicines Partnership (AMP)...

Lupus 4
2014-09-04 06:52:11

Richard Hook, ESO Lupus 4, a spider-shaped blob of gas and dust, blots out background stars like a dark cloud on a moonless night in this intriguing new image. Although gloomy for now, dense pockets of material within clouds such as Lupus 4 are where new stars form and where they will later burst into radiant life. The Wide Field Imager on the MPG/ESO 2.2-metre telescope at ESO’s La Silla Observatory in Chile captured this new picture. [ Watch the Video: A Close-Up View Of The Dark...

2014-08-12 11:10:06

Wiley Readmissions more likely in black and Hispanic systemic lupus erythematosus patients A new study reveals that one in six patients with systemic lupus erythematosus (SLE) is readmitted to the hospital within 30 days of being discharged. Results published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), show that black and Hispanic SLE patients were more likely to be readmitted than white patients. Readmissions among patients insured by...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »
Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.